Works across neurodegeneration and cognitive aging, blending CSF/plasma proteomics, lipidomics, and network modeling with machine learning and sleep-based monitoring to map disease pathways, improve risk stratification, and prioritize therapeutic targets in Alzheimer’s and Lewy body disorders.